Parkinson Research
In doing proper
Parkinson
Research you
first need to
identify the
problem. The disease
is no the focus of
the problem it is
the problems
experienced during
treatment. The
Parkinson
Research of
NeuroResearch
Clinics has found a
away to address
these problems.
Traditional
treatment of
Parkinsons
in medicine involves
the use of the amino
acid levodopa with
carbidopa and dopamine
agonists. Problems include
drugs that quit
working and side
effects. Typically,
symptoms gradually
gets worse over
time. In 2001
NeuroResearch
Clinics realized
that virtually all the problems associated
with standard
Parkinsons
treatment stemmed from
improper use of the
levodopa and carbidopa.
These problems can
be categorized into
four areas:
-
levodopa
side effects due to being
improperly
balanced with
serotonin
nutrients.
-
Depletion
of serotonin by
levodopa,
during
treatment. When
serotonin levels
drop low enough
the levodopa quits
working and
symptoms
associated with serotonin depletion
develop.
-
Depletion of the
sulfur amino acids by
levodopa.
This leads to
depletion of
glutathione
causing more
brain damage from
neurotoxins, making the
Parkinsons
worse. Depletion of
sulfur amino acids
causes depletion of
adrenaline causing
the
patient to move very
slow.
-
Carbidopa depletes serotonin
and
dopamine
peripherally causing
numerous side effects.
Treatment of Parkinsons
should not be with only
levodopa.
Parkinsons
treatment should be
with
properly balanced
levodopa, 5-HTP,
tyrosine, cysteine
guided by neurotransmitter testing as indicted. Use of of
this combination of
nutrient controls
the side effect of
nausea associated
with levodopa and
prevents the
depletion of
serotonin and
glutathione in
treatment. It also helps
prevent progression
of Parkinsons due to
glutathione
depletion which is
needed to prevent
further neurotoxic.
Parkinson Research
|
